Related Experiment Video
Updated: May 22, 2026

Assessment of Mitochondrial Functions and Cell Viability in Renal Cells Overexpressing Protein Kinase C Isozymes
Published on: January 7, 2013
p57(KIP2) control of actin cytoskeleton dynamics is responsible for its mitochondrial pro-apoptotic effect
E Kavanagh1, P Vlachos, V Emourgeon
1Department of Oncology-Pathology, Cancer Centrum Karolinska, R8:03, Karolinska Institutet, SE-171 76 Stockholm, Sweden.
Abstract:
p57 (Kip2, cyclin-dependent kinase inhibitor 1C), often found downregulated in cancer, is reported to hold tumor suppressor properties. Originally described as a cyclin-dependent kinase (cdk) inhibitor, p57(KIP2) has since been shown to influence other cellular processes, beyond cell cycle regulation, including cell death and cell migration. Inhibition of cell migration by p57(KIP2) is attributed to the stabilization of the actin cytoskeleton through the activation of LIM domain kinase-1 (LIMK-1). Furthermore, p57(KIP2) is able to enhance mitochondrial-mediated apoptosis. Here, we report that the cell death promoting effect of p57(KIP2) is linked to its effect on the actin cytoskeleton. Indeed, whereas Jasplakinolide, an actin cytoskeleton-stabilizing agent, mimicked p57(KIP2)'s pro-apoptotic effect, destabilizing the actin cytoskeleton with cytochalsin D reversed p57(KIP2)'s pro-apoptotic function. Conversely, LIMK-1, the enzyme mediating p57(KIP2)'s effect on the actin cytoskeleton, was required for p57(KIP2)'s death promoting effect. Finally, p57(KIP2-)mediated stabilization of the actin cytoskeleton was associated with the displacement of hexokinase-1, an inhibitor of the mitochondrial voltage-dependent anion channel, from the mitochondria, providing a possible mechanism for the promotion of the mitochondrial apoptotic cell death pathway. Altogether, our findings link together two tumor suppressor properties of p57(KIP2), by showing that the promotion of cell death by p57(KIP2) requires its actin cytoskeleton stabilization function.
Insights
The tumor suppressor p57 (cyclin-dependent kinase inhibitor 1C) promotes cell death by stabilizing the actin cytoskeleton. This stabilization is crucial for p57
Area of Science:
- Molecular Biology
- Cell Biology
- Biochemistry
Background:
- p57 (cyclin-dependent kinase inhibitor 1C) is a tumor suppressor often downregulated in cancer.
- p57 regulates processes beyond cell cycle control, including apoptosis and cell migration.
- p57 inhibits cell migration by stabilizing the actin cytoskeleton via LIM domain kinase-1 (LIMK-1).
Purpose of the Study:
- To investigate the link between p57's pro-apoptotic effect and its influence on the actin cytoskeleton.
- To elucidate the mechanism by which p57 promotes mitochondrial-mediated apoptosis.
Main Methods:
- Utilized actin cytoskeleton-stabilizing (Jasplakinolide) and destabilizing (cytochalsin D) agents.
- Assessed the requirement of LIMK-1 for p57's pro-apoptotic function.
- Examined the association between p57-mediated actin stabilization and hexokinase-1 localization at mitochondria.
Main Results:
- Actin cytoskeleton stabilization mimicked p57's pro-apoptotic effect, while destabilization reversed it.
- LIMK-1 was essential for p57 to promote cell death.
- p57-mediated actin stabilization led to hexokinase-1 displacement from mitochondria, facilitating apoptosis.
Conclusions:
- p57's tumor suppressor function in promoting cell death is dependent on its ability to stabilize the actin cytoskeleton.
- This study links p57's effects on the actin cytoskeleton to its role in initiating mitochondrial apoptosis.
- The findings provide a mechanistic link between p57's cytoskeletal regulation and its tumor suppressor activity.
Related Concept Videos
The Intrinsic Apoptotic Pathway
Abnormal Proliferation
The Extrinsic Apoptotic Pathway
Anaphase Promoting Complex
PI3K/mTOR/AKT Signaling Pathway
Caspases

